BSEM logo

BSEM BioStem Technologies, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$0.64
-0.07 (-10.23%)

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue woun…

Market Cap: $12.18Mbiostemtechnologies.com

Price

No data yet.

Social Signal Score

47
5d
—
30d
50
1 mentions
—
60d
45
4 mentions
—
90d
45
8 mentions
—
news: 8

Analyst Ratings

Avg price target$7+1002.2%
Low $7Median $7High $7
Current Consensus

Revenue

$7.64M+8738.40%
$-84.82M$-22.25M$40.31M$102.87M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.26
$0.26–$0.26
1 analysts
FY2026
$-1.90-831% YoY
$-1.90–$-1.90
1 analysts
FY2027
$-1.04
$-1.04–$-1.04
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jason Matuszewski
Sector
Healthcare
Industry
Biotechnology
Employees
73
Beta
0.27
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-5.68
biostemtechnologies.com